Chronic Medications for Maintenance of Lung Health

Publication Date: January 3, 2013
Last Updated: March 14, 2022

RECOMMENDATIONS

UNCHANGED FROM 2007

Inhaled tobramycin—moderate to severe disease

For individuals with CF 6 years of age and older, with moderate to severe lung disease and Pseudomonas aeruginosa persistently present in cultures of the airways, the CF Foundation strongly recommends the chronic use of inhaled tobramycin to improve lung function and quality of life, and reduce exacerbations. (A)
322325

Overview

Title

Chronic Medications for Maintenance of Lung Health

Authoring Organization